SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 171.95 |
| Enterprise Value ($M) | 179.15 |
| Book Value ($M) | -89.39 |
| Book Value / Share | -0.07 |
| Price / Book | -1.92 |
| NCAV ($M) | -89.63 |
| NCAV / Share | -0.07 |
| Price / NCAV | -1.92 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.54 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.35 |
| Current Ratio | 0.35 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 24.63 |
| Assets | 24.88 |
| Liabilities | 114.27 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -18.06 |
| Net Income | -49.84 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -10.98 |
| Cash from Investing | 0.00 |
| Cash from Financing | 11.75 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Welch David F | 5.10 | -2.03 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| CURLF – Curaleaf Holdings, Inc. | CVSI – CV Sciences, Inc. |
| CYAN – Cyanotech Corporation | DBVTF – DBV Technologies S.A. |
| DMKPQ – DMK Pharmaceuticals Corporation |
Financial data and stock pages provided by
Fintel.io